Terra Sigillata

As tipped off by Brother Orac this morning: from “60 pct of cancer patients try nontraditional med”:

Some people who try unproven remedies risk only money. But people with cancer can lose their only chance of beating the disease by skipping conventional treatment or by mixing in other therapies. Even harmless-sounding vitamins and “natural” supplements can interfere with cancer medicines or affect hormones that help cancer grow.

This is mainstream sci/med journalism done right. Period.

Comments

  1. #1 JE
    June 9, 2009

    An equally important issue is whether chemotherapy has any value at all. Many doctors don’t seem to think so:

    http://www.curenaturalicancro.com/2-physicians-refuse-chemo.html

    Some supplements, like melatonin, either by themselves, or in conjunction with other therapies may be effective in treating breast cancer:

    http://www.lef.org/protocols/prtcl-022g.shtml

  2. #2 Tercel
    June 9, 2009

    And once again, blog comments prove that some people just don’t get the point, ever.

  3. #3 Left_Wing_Fox
    June 9, 2009

    Very nice article.

    I was worried about the “Even harmless-sounding vitamins and ‘natural’ supplements can interfere with cancer medicines or affect hormones that help cancer grow.” bit in your snippet, just because so many articles these days fail to give any examples to back up the claim. So I was impressed that she listed a number of such examples, as well as the mechanisms as to why they cause complications. Good stuff!

  4. #4 Toaster
    June 9, 2009

    Dear JE,

    Dr. Simoncini also thinks that a gut imbalance in yeast causes cancer and invokes ooga-booga mystery toxins as a mechanism for it. This discredits him thoroughly all by itself. Your link to his site claiming that sodium bicarbonate can cure cancer just furthers the evidence that he is pathologically deranged and willfully ignorant of both reality and evidence. You know what sodium bicarbonate is in? Pepto-Bismol! Are you seriously trying to tell us that Pepto can cure cancer?

    Are you even listening to yourself?

    With concern,
    Toaster

  5. #5 JE
    June 9, 2009

    Tercel, It seemed to me Marilynn Marchione was trying to make this point:

    When it comes to cancer, ALL “alternative therapies” are a waste of money, possibly even harmful.

    While undoubtedly some therapies are a waste of money, there is scientific evidence supporting the use of dietary supplements for some cancers. Do you disagree?

  6. #6 Kathryn
    June 9, 2009

    JE,

    Without any citations for the “scientific evidence supporting the use of dietary supplements for some cancers,” it’s hard to agree or disagree with your statement.

    If you mean that cancer patients may need vitamin or mineral supplements because of malabsorption etc. during treatment, that’s true–but nutrition isn’t an alternative therapy. It isn’t alternative therapy to practice meditation as stress-relief or tai chi as balance training.

    Because these straightforward applications of nutrition and self-care are uncontroversial, many alt-med proponents use them as the thin end of the wedge. If they can get rational people to admit these are OK, then they extend this admission to the truly alternative (as in unfounded and unproven) modalities.

    –Kathryn

  7. #7 Kathryn
    June 9, 2009

    Actually, I retract my comment about supplements being beneficial *at all* during cancer. According to this article’s sources, the American Cancer Society discourages their use during cancer treatment because vitamins and minerals can help the cancer cells fight chemotherapy, radiation, etc.

    http://well.blogs.nytimes.com/2009/06/08/worries-about-antioxidant-use-by-breast-cancer-patients/

    http://caonline.amcancersoc.org/cgi/content/abstract/55/5/319

    –Kathryn

  8. #8 Kevin Curry
    June 10, 2009

    “to the cancer establishment, a cancer patient is a profit center.the actual clinical and scientific evidence does not support the cancer industry.conventional cancer treatments are in place as the law of the land because they pay, not cure opr heal the best. decades of the politics-of-cancer-as-usual have kept you from knowing this, and will continue doing this until you wake up to their reality”
    Quote by Dr. John Diamond MD

  9. #9 Ralph
    June 11, 2009

    Wow,do your research people. A vitamin or an herb is a substance, not a sports team. My gosh, Taxol for example was from the yew tree.

    There are no absolutes….I research this stuff. There are large amounts of adequate data to support the use of certain supplements for a number of conditions. Whether it be in conjuction with another chemical or stand alone.

    People’s lives are in play here. Yes the original author of this blog described the Will-O-Wisp principle in regards the using the limited resources of a cancer patient..

    Let me just give you the title to a few research papers released just in the past two weeks 24MAY to 09JUN…

    Green tea extract shows promise in leukemia trials
    Omega fatty acid balance can alter immunity and gene expression
    Multivitamins in pregnancy reduce risk of low birth weights
    Stopping diabetes damage with vitamin C

    If you choose to speak in absolutes, than please don’t call yourself a scientist. There is bad and good in many things. No one field of science should take a monopoly on any field of thought…Gee who invented Penicillin?

  10. #10 Karlita
    June 11, 2009

    Actually, I’ve seen several articles by Marilynn Marchione. I googled her name, because I was wondering who was so intent on doing a total slam job on alternative medicine. She’s written several negative articles about alternative medicine in a row. It makes me wonder what her monetary interest is. She isn’t reporting things like the fact that the conventional medical industry is killing more people each year than car wrecks, or that conventional medicine is losing billions of dollars every year to alternative medicine, because people are fed up with the elitism and greed in conventional medicine. I know that there are a lot of quacks out there. Unfortunately, I’ve found most of them have an MD after their names.

  11. #11 anon
    June 12, 2009

    “Wow,do your research people. A vitamin or an herb is a substance, not a sports team. My gosh, Taxol for example was from the yew tree.”

    Ralph, no disrespect, but perhaps you might do some research and read this blogger’s credentials– he and other researchers in his field are the sort that do the research to find that things like taxol have anti-cancer properties (and things like green tea etc etc)…but also understand, that a person would have to eat the bark of something like 2 yew trees for a taxol treatment….

  12. #12 Evan Harper
    June 12, 2009

    I found your posting after Googling her name in order to answer exactly the same question. Let me register my disgust with commenters like “Karlita,” who dogmatically insist that anyone who disagrees with their dubious belief-system must be a paid flunky for Big Pharma. Look at her double standards; she blames “car wrecks” when people die in car accidents, but she blames “the conventional medical industry” when people die in medical accidents.

    Let’s be clear. The phrase “dietary supplement” is not a medical or scientific term. It is a LEGAL term. It refers to a class of substances which receive preferential treatment under the current American legal regime. A substance sold to treat a disease is NOT a dietary supplement! This is a matter of DEFINITION, and as such, it is perfectly appropriate to be black-and-white about it.

  13. #13 Evan Harper
    June 12, 2009

    Oh, by the way, you can find more of her wonderful work at http://ap-283.newsvine.com/

  14. #14 s. garrett
    June 21, 2009

    a Well “covered” reporter….check page 9 of this journalistic newsletter of 2004….. Seems she graduated in 76′ and will just say seems she forgot what her great &/or even grandmother might have taught her about herbs….. and what traditional (medicine) really means…. from her alumni journal from Kent State University Jargon_Fall04.pdf
    …”has been named medical writer for the associated press. the former medical reporter for the milwaukee journal sentinel, is a native of youngstown. she also worked for the chicago sun times and the akron beacon jouurnal.”
    Amazing how folks get to be authorities about stuff they aren’t authorities on.

  15. #15 Killshot
    June 26, 2009

    Good thread. I am a bd certified internist who practiced in a large hospital system for ~ 20 years before leaving to establish an integrative practice with broader applications to health and illness. I taught nutraceutical science in a large state university college of pharmacy for 6 years. I am a past president of my state medical society. Ms Marchione’s journalism is little more than uninformed tripe, very selective citations, and a clearly prejudicial viewpoint likely funded by mainstream interests. I have seen this before. Luckily, the majority of patients are beyond her puerile rants and will discover for themselves what does and does not work.

  16. #16 Skip Cameron
    July 19, 2009

    Can’t always trust what you read in the paper these days.
    It really chagrin’s me how far current news writers (who are neither reporters or journalists) have moved away from
    good old Walter Cronkite journalism. Cronkite remarked a while back that the new generation of writers are better educated but want to editorialize and don’t research their stories thoroughly from all sides and are into sound bites over substance.
    AP journalist (I don’t think she has ‘earned’ this title) Marilynn Marchione has quite a reputation as a slam dog writer, especially when it comes to putting down non-pharmaceutical approaches to healing.
    She also distorts and misrepresents the value of latest and improved surgical procedures.
    Her July 15 AP release on the higher risk for the new leg vein removal procedure for heart bypass is typical Marilyn, makes a mountain out of a mouse hole. My comments on the major news blogs is this:
    This article points out a risk that is probably not there. The difference of a little over 1% in the two vein extraction procedures is probably within the statistical error of the populations studied. And if the detail health profile of the subjects in the study were analyzed, for other major health issues and histories the subjects, the results might show that the less invasive “porthole” vein removal procedure is far superior to the old “fillet the leg” procedure. I had the “porthole” procedure for 5 bypasses last December 4, and had no problems with the leg, compared to many horror stories I have heard from friends who had their leg “filleted”. The wide variety of patient conditions I observed in my visits to cardiac rehabilitation tells me that there are many facts missing and not presented here, typical of of the sound bite journalism we all see these days. In memory of “Walter Cronkite’s credibility” in journalism, give us in the
    “rest of the story”.

  17. #17 Rene
    July 23, 2009

    WOW- MARILYNN MARCHIONE must be getting some REALLY DECENT HIGH QUALITY Lawn furniture from the “cancer clubs” and Big Pharma… Not to even give alternative medicine or supplement companies their day in court???… Pure Nazi journalism at its finest…
    Ms. Marchione needs to read “The Secret History of the War on Cancer” just for starters…Then maybe she can write with the big girls… Literally: BAD NEWS!

  18. #18 Bill Cassidy
    July 31, 2009

    What are MARILYNN MARCHIONE credentials?

    Her article on supplements is full of holes and does not indicate sufficient research to appear in any publication!

  19. #19 Disenchanted
    November 4, 2009

    Such a terrific job? Try horrific job! Having recently read a piece that’s been circulating the nation about menopause driving many to try ‘natural’ therapies, I am shocked she’s employed as a “journalist”. Grade school students write better argument papers than this woman. The blatant word twisting and misrepresentation is precisely the type of writing that puts a big black badge of shame on the media’s wall of blame. When reading pieces written by Marilynn Marchione, it is wisest to think you’re in the “opinion” section rather than in the news section because her twisted statements, and misdirected slandering, one-sided slanting, and her irrelevant “sources” put forth a work of complete and baffling untruth.

  20. #20 Alexis Baranek
    November 8, 2009

    The series of articles by Marilyn Marcione are about the most biased, uninformed nonsense I’ve read in awhile. As one who has benefited greatly from natural medicine – which means not poisoning yourself with “FDA approved” drugs that have been proven over and over to cause numerous often deadly side effects – I am really amazed at the total stupidity! Obviously her interests and that of AP lie in protecting drug company profits! Get the facts and find out how many people are killed pharmeceuticals each year! Why is it so hard for you to accept that giving the body the nutrients it needs to help heal itself and getting rid of poisons is the way to real health. Your thinking is one of the reasons more and more Americans are chronically ill and the so called health care system (really sick care) is in a crisis. I’m disgusted and so are numerous other informed, intelligent people!

  21. #21 Jason Bussell
    November 10, 2009

    I agree that this woman seems blatantly biased. She claims placebo is the only thing that works about “alternative therapies”. Why does no one seem to believe that Western therapy will work? I am an acupuncturist. Many people come to me after trying many other, more-conventional treatments that they expected to work. Most of the people who come to me are at least somewhat skeptical about acupuncture’s ability to help them, but often it does. If belief was the greatest factor, then they should’ve seen improvement from the Cortisone shot, or the PT, or the anti-inflammatory, or the muscle relaxers, or the surgery.

    The randomized controlled, double-blind study works best with pills. I read skeptics saying that this is the only way to prove something works. I challenge anyone to show me the RCT of hip replacements. It is impossible for you as a patient to not know whether or not he/she had a hip replacement, and it is impossible for a surgeon to not know whether or not he/she replaced that hip. According to the skeptics, any relief found by these hip replacement patients must be due to placebo.

    And what about the animal studies that show improvement in function, rom, increased immune-system levels, etc. Animals are notorious skeptics.

    The body works on many levels. To think you know it all is when you stop learning.

  22. #22 Eddie smith
    November 10, 2009

    She’s unbelievable, and never takes personal e-mails either. What does that tell you? An entire outreach of the AMA called Naturopathic medicine does just what she claims isn’t so. I’d LOVE to see her go toe to toe with Dr. Merolla or Dr. Blaylock and his peer reviewed research!

  23. #23 TL
    November 10, 2009

    Seems others searched for more information on this writer also, I was curious if I could find anything on how she is linked to Pharma.

    Personally going through a 4 year long health crisis, trying extensively conventional and finally researching alternative therapy as a matter of survival. I learned a personal lesson about the dangers and costs of listening to this type of propaganda. Wake up and stay alive.

  24. #24 Rain Bojangles
    November 11, 2009

    I only needed to read one article by MARILYNN MARCHIONE to quickly determine that she is either an obvious shill for big Med or an uneducated person who is doing all her research in the shallow end of the information pool. Her blanket statement “Ten years and $2.5 billion in research have found no cures from alternative medicine.” is followed by a sentence which contradicts the first “Yet these mostly unproven treatments are now…..”. How are “alternative treatments” unproven yet mostly unproven. She is either a bad writer or she is not mentally competent to be writing articles which could impact the lives and health of innocent and vulnerable people. Many, many drugs were derived from plants and many herbs are very effective against a wide variety of imbalances in the bodies of humans and other animals. I hope no one takes her inane scribblings seriously because she does not deserve consideration as a viable “journalist”, and certainly not on the topic of health. I have one expression to describe her empty fluff. Pfffffft!

  25. #25 Rain Bojangles
    November 11, 2009

    CORRECTION:

    The quote in my comment was the “Editors Note” which prefaced the article. Still a very badly written introduction to her hit piece, even if not her words.

  26. #26 Kayall
    November 12, 2009

    40 years and how many billions of wasted dollars have gone to the American Cancer Society with no cure, and no cures in sight, with treatments still consisting of chemo, radiation, and surgery.
    Why do I care? Because I watched as these barbaric, outdated treatments were used on my daughter, who passed after two tortured years, with the treatment way worse than the disease.
    Here’s some facts from The Cancer Prevention Coalition. http://www.preventcancer.com/about/

    The American Cancer Society is fixated on damage control— diagnosis and treatment— and basic molecular biology, with indifference or even hostility to cancer prevention. This myopic mindset is compounded by interlocking conflicts of interest with the cancer drug, mammography, and other industries. The “nonprofit” status of the Society is in sharp conflict with its high overhead and expenses, excessive reserves of assets and contributions to political parties. All attempts to reform the Society over the past two decades have failed; a national economic boycott of the Society is long overdue.

    The American Cancer Society (ACS) is accumulating great wealth in its role as a “charity.” According to James Bennett, professor of economics at George Mason University and recognized authority on charitable organizations, in 1988 the ACS held a fund balance of over $400 million with about $69 million of holdings in land, buildings, and equipment (1). Of that money, the ACS spent only $90 million— 26 percent of its budget— on medical research and programs. The rest covered “operating expenses,” including about 60 percent for generous salaries, pensions, executive benefits, and overhead. By 1989, the cash reserves of the ACS were worth more than $700 million (2). In 1991, Americans, believing they were contributing to fighting cancer, gave nearly $350 million to the ACS, 6 percent more than the previous year. Most of this money comes from public donations averaging $3,500, and high-profile fund-raising campaigns such
    as the springtime daffodil sale and the May relay races. However, over the last two decades, an increasing proportion of the ACS budget comes from large corporations, including the pharmaceutical, cancer drug, telecommunications, and entertainment industries.

    In 1992, the American Cancer Society Foundation was created to allow the ACS to actively solicit contributions of more than $100,000. However, a close look at the heavy-hitters on the Foundation’s board will give an idea of which interests are at play and where the Foundation expects its big contributions to come from. The Foundation’s board of trustees included corporate executives from the pharmaceutical, investment, banking, and media industries. Among them:

    * David R. Bethune, president of Lederle Laboratories, a multinational pharmaceutical company and a division of American Cyanamid Company. Bethune is also vice president of American Cyanamid, which makes chemical fertilizers and herbicides while transforming itself into a full-fledged pharmaceutical company. In 1988, American Cyanamid introduced Novatrone, an anti-cancer drug. And in 1992, it announced that it would buy a majority of shares of Immunex, a cancer drug maker.

    * Multimillionaire Irwin Beck, whose father, William Henry Beck, founded the nation’s largest family-owned retail chain, Beck Stores, which analysts estimate brought in revenues of $1.7 billion in 1993.

    * Gordon Binder, CEO of Amgen, the world’s foremost biotechnology company, with over $1 billion in product sales in 1992. Amgen’s success rests almost exclusively on one product, Neupogen, which is administered to chemotherapy patients to stimulate their production of white blood cells. As the cancer epidemic grows, sales for Neupogen continue to skyrocket.

    * Diane Disney Miller, daughter of the conservative multi-millionaire Walt Disney, who died of lung cancer in 1966, and wife of Ron Miller, former president of the Walt Disney Company from 1980 to 1984.
    * George Dessert, famous in media circles for his former role as censor on the subject of “family values” during the 1970s and 1980s as CEO of CBS, and now chairman of the ACS board.

    * Alan Gevertzen, chairman of the board of Boeing, the world’s number one commercial aircraft maker with net sales of $30 billion in 1992.

    * Sumner M. Redstone, chairman of the board, Viacom Inc. and Viacom International Inc., a broadcasting, telecommunications, entertainment, and cable television corporation.

    The results of this board’s efforts have been very successful. A million here, a million there— much of it coming from the very industries instrumental in shaping ACS policy, or profiting from it. In 1992, The Chronicle of Philanthropy reported that the ACS was “more interested in accumulating wealth than in saving lives.” Fund-raising appeals
    routinely stated that the ACS needed more funds to support its cancer programs, all the while holding more than $750 million in cash and real estate assets (3). A 1992 article in the Wall Street Journal, by Thomas DiLorenzo, professor of economics at Loyola College and veteran investigator of nonprofit organizations, revealed that the Texas affiliate of the ACS owned more than $11 million worth of assets in land and real estate, as well as more than 56 vehicles, including
    11 Ford Crown Victorias for senior executives and 45 other cars assigned to staff members. Arizona’s ACS chapter spent less than 10 percent of its funds on direct community cancer services. In California, the figure was 11 percent, and under 9 percent in Missouri (4):

    Thus for every $1 spent on direct service, approximately $6.40 is spent on compensation and overhead. In all ten states, salaries and fringe benefits are by far the largest single budget items, a surprising fact in light of the characterization of the appeals, which stress an urgent and critical need for donations to provide cancer services.

    Nationally, only 16 percent or less of all money raised is spent on direct services to cancer victims, like driving cancer patients from the hospital after chemotherapy and providing pain medication.

    Most of the funds raised by the ACS go to pay overhead, salaries, fringe benefits, and travel expenses of its national executives in Atlanta. They also go to pay chief executive officers, who earn six-figure salaries in several states, and the hundreds of other employees who work out of some 3,000 regional offices nationwide. The typical ACS affiliate, which helps raise the money for the national office, spends more than 52 percent of its budget on salaries, pensions, fringe benefits, and overhead for its own employees. Salaries and overhead for most ACS affiliates also exceeded 50 percent, although most direct community services are handled by unpaid volunteers. DiLorenzo summed up his findings by emphasizing the hoarding of funds by the ACS (4):

    If current needs are not being met because of insufficient funds, as fund-raising appeals suggest, why is so much cash being hoarded? Most contributors believe their donations are being used to fight cancer, not to accumulate financial reserves. More progress in the war against cancer would be made if they would divest some of their real estate holdings and use the proceeds— as well as a portion of their cash reserves— to provide more cancer services.

    Aside from high salaries and overhead, most of what is left of the ACS budget goes to basic research and research into profitable patented cancer drugs. The current budget of the ACS is $380 million and its cash reserves approach $1 billion. Yet its aggressive fund-raising campaign continues to plead poverty and lament the lack of available money for cancer research, while ignoring efforts to prevent cancer by phasing out avoidable exposures to environmental and occupational carcinogens. Meanwhile, the ACS is silent about its intricate
    relationships with the wealthy cancer drug, chemical, and other industries. A March 30, 1998, Associated Press Release shed unexpected light on questionable ACS expenditures on lobbying (5). National vice president for federal and state governmental relations Linda Hay Crawford admitted that the ACS was spending “less than $1 million a year on direct lobbying.” She also admitted that over the last year, the society used ten of its own employees to lobby. “For legal
    and other help, it hired the lobbying firm of Hogan & Hartson, whose roster includes former House Minority Leader Robert H. Michel (R– IL).” The ACS lobbying also included $30,000 donations to Democratic and Republican governors’ associations. “We wanted to look like players and be players,” explained Crawford. This practice, however, has been sharply challenged. The Associated Press release quotes the national Charities Information Bureau as stating that it” does not know of any other charity that makes contributions to political parties.”
    Tax experts have warned that these contributions may be illegal, as charities are not allowed to make political donations. Marcus Owens, director of the IRS Exempt Organization Division, also warned that “The bottom line is campaign contributions will jeopardize a charity’s exempt status.”

    TRACK RECORD ON PREVENTION
    Marching in lockstep with the National Cancer Institute (NCI) in its “war” on cancer is its “ministry of information,” the ACS (6, pp. 306– 314). With powerful media control and public relations resources, the ACS is the tail that wags the dog of the policies and priorities of the NCI (7, 8). In addition, the approach of the ACS to cancer prevention reflects a virtually exclusive “blame-the-victim” philosophy. It emphasizes faulty lifestyles rather than unknowing and avoidable
    exposure to workplace or environmental carcinogens. Giant corporations, which profit handsomely while they pollute the air, water, and food with a wide range of carcinogens, are greatly comforted by the silence of the ACS. This silence reflects a complex of mindsets fixated on diagnosis, treatment, and basic genetic research together with ignorance, indifference, and even hostility to prevention, coupled with conflicts of interest.

    Indeed, despite promises to the public to do everything to “wipe out cancer in your lifetime,” the ACS fails to make its voice heard in Congress and the regulatory arena. Instead, the ACS repeatedly rejects or ignores opportunities and requests from Congressional committees, regulatory agencies, unions, and environmental organizations to provide scientific testimony critical to efforts
    to legislate and regulate a wide range of occupational and environmental carcinogens. This history of ACS unresponsiveness is a long and damning one, as shown by the following examples (6):

    1. In 1971, when studies unequivocally proved that diethylstilbestrol (DES) caused vaginal cancers in teenaged daughters of women administered the drug during pregnancy, the ACS refused an invitation to testify at Congressional hearings to require the FDA (U. S. Food and Drug Administration) to ban its use as an animal feed additive. It gave no reason for its refusal.

    2. In 1977 and 1978, the ACS opposed regulations proposed for hair coloring products that contained dyes known to cause breast and liver cancer in rodents. In so doing, the ACS ignored virtually every tenet of responsible public health as these chemicals were clear-cut liver and breast carcinogens.

    3. In 1977, the ACS called for a Congressional moratorium on the FDA’s proposed ban on saccharin and even advocated its use by nursing mothers and babies in “moderation” despite clear-cut evidence of its carcinogenicity in rodents. This reflects the consistent rejection by the ACS of the importance of animal evidence as predictive of human cancer risk.

    4. In 1978, Tony Mazzocchi, then senior representative of the Oil, Chemical, and Atomic Workers International Union, stated at a Washington, D. C., round-table between public interest groups and high-ranking ACS officials: “Occupational safety standards have received no support from the ACS.”

    5. In 1978, Congressman Paul Rogers censured the ACS for doing “too little, too late” in failing to support the Clean Air Act.

    6. In 1982, the ACS adopted a highly restrictive cancer policy that insisted on unequivocal human evidence of carcinogenicity before taking any position on public health hazards. Accordingly, the ACS still trivializes or rejects evidence of carcinogenicity in experimental animals, and has actively campaigned against laws (the 1958 Delaney Law, for instance) that ban deliberate addition to food of
    any amount of any additive shown to cause cancer in either animals or humans. The ACS still persists in an anti-Delaney policy, in spite of the overwhelming support for the Delaney Law by the independent scientific community.

    7. In 1983, the ACS refused to join a coalition of the March of Dimes, American Heart Association, and the American Lung Association to support the Clean Air Act.

    8. In 1992, the ACS issued a joint statement with the Chlorine Institute in support of the continued global use of organochlorine pesticides— despite clear evidence that some were known to cause breast cancer. In this statement, Society vice president Clark Heath, M. D., dismissed evidence of this risk as “preliminary and mostly based on weak and indirect association.” Heath then went on to explain away the blame for increasing breast cancer rates as due to better detection: ” Speculation that such exposures account for observed geographic differences in breast cancer incidence or for recent rises in breast cancer occurrence should be received with caution; more likely, much of the recent rise in incidence in the United States . . . reflects increased utilization of mammography over the past decade.”

    9. In 1992, in conjunction with the NCI, the ACS aggressively launched a ” chemoprevention” program aimed at recruiting 16,000 healthy women at supposedly ” high risk” of breast cancer into a 5-year clinical trial with a highly profitable drug called tamoxifen. This drug is manufactured by one of the world’s most powerful cancer drug industries, Zeneca, an offshoot of the Imperial Chemical Industries. The women were told that the drug was essentially harmless, and that it could reduce their risk of breast cancer. What the women were not told was that tamoxifen had already been shown to be a highly potent liver carcinogen in rodent tests, and also that it was well-known to induce human uterine cancer (6, pp. 145– 151).

    10. In 1993, just before PBS Frontline aired the special entitled “In Our
    Children’s Food,” the ACS came out in support of the pesticide industry. In a damage-control memorandum sent to some 48 regional divisions, the ACS trivialized pesticides as a cause of childhood cancer, and reassured the public that carcinogenic pesticide residues in food are safe, even for babies. When the media and concerned citizens called local ACS chapters, they received reassurances
    from an ACS memorandum by its vice president for Public Relations (9): “

    The primary health hazards of pesticides are from direct contact with the chemicals at potentially high doses, for example, farm workers who apply the chemicals and work in the fields after the pesticides have been applied, and people living near aerially sprayed fields. . . . The American Cancer Society believes that the benefits of a balanced diet rich in fruits and vegetables far outweigh the largely theoretical risks posed by occasional, very low pesticide
    residue levels in foods.”

    11. In September 1996, the ACS together with a diverse group of patient and physician organizations filed a “citizen’s petition” to pressure the FDA to ease restrictions on access to silicone gel breast implants. What the ACS did not disclose was that the gel in these implants had clearly been shown to induce cancer in several industry rodent studies, and that these implants were also contaminated
    with other potent carcinogens such as ethylene oxide and crystalline silica. This abysmal track record on prevention has been the subject of periodic protests by both independent scientists and public interest groups. A well-publicized example was a New York City, January 23, 1994, press conference, sponsored by the author and the Center for Science in the Public Interest. The press release stated: “A group of 24 scientists charged that the ACS was doing little to protect the public from cancer-causing chemicals in the environment and workplace. The scientists urged ACS to revamp its policies and to emphasize prevention in its lobbying and educational campaigns.” The
    scientists— who included Matthew Meselson and Nobel laureate George Wald, both of Harvard University; former OSHA director Eula Bingham; Samuel Epstein, author of The Politics of Cancer; and Anthony Robbins, past president of the American Public Health Association— criticized the ACS for insisting on unequivocal human proof that a substance is carcinogenic before it will recommend its regulation.

    This public criticism by a broad representation of highly credible scientists reflects the growing conviction that a substantial proportion of cancer deaths are caused by exposure to chemical carcinogens in the air, water, food supply, and workplace, and thus can be prevented by legislative and regulatory action. Calling the ACS guidelines an “unrealistically high-action threshold,” a letter to ACS executive vice president Lane Adams states that “we would like to express
    our hope that ACS will take strong public positions and become a more active force to protect the public and the work force from exposure to carcinogens.” ACS’s policy is retrogressive and contrary to authoritative and scientific tenets established by international and national scientific committees, and is in conflict with long-established policies of federal regulatory agencies. Speakers at the conference warned that unless the ACS became more supportive of cancer prevention, it would face the risk of an economic boycott. Reacting promptly, the ACS issued a statement claiming that cancer prevention would become a major priority. However, ACS policies have remained unchanged. More recently, the author has issued this warning again, a warning echoed by activist women’s breast cancer groups.

    In Cancer Facts & Figures— 1998, the latest annual ACS publication designed to provide the public and medical profession with “Basic Facts” on cancer— other than information on incidence, mortality, signs and symptoms, and treatment— there is little or no mention of prevention (10). Examples include: no mention of dusting the genital area with talc as a known cause of ovarian cancer; no mention of parental exposure to occupational carcinogens as a major cause of
    childhood cancer; and no mention of prolonged use of oral contraceptives and hormone replacement therapy as major causes of breast cancer. For breast cancer, ACS states: “Since women may not be able to alter their personal risk factors, the best opportunity for reducing morality is through early detection.” In other words, breast cancer is not preventable in spite of clear evidence that its incidence
    has escalated over recent decades, and in spite of an overwhelming literature on avoidable causes of this cancer (6, Chapt. 6). In the section on “Nutrition and Diet,” no mention at all is made of the heavy contamination of animal and dairy fats and produce with a wide range of carcinogenic pesticide residues, and on the need to switch to safer organic foods.

    CONFLICTS OF INTEREST
    Of the members of the ACS board, about half are clinicians, oncologists, surgeons, radiologists, and basic molecular scientists— and most are closely tied in with the NCI. Many board members and their institutional colleagues apply for and obtain funding from both the ACS and the NCI. Substantial NCI funds go to ACS directors who sit on key NCI committees. Although the ACS asks board members to leave the room when the rest of the board discusses their funding
    proposals, this is just a token formality. In this private club, easy access to funding is one of the “perks,” and the board routinely rubber-stamps approvals. A significant amount of ACS research funding goes to this extended membership. Such conflicts of interest are evident in many ACS priorities, including their policy on mammography and their National Breast Cancer Awareness campaign (6).

    Mammography
    The ACS has close connections to the mammography industry. Five radiologists have served as ACS presidents, and in its every move, the ACS reflects the interests of the major manufacturers of mammogram machines and films, including Siemens, DuPont, General Electric, Eastman Kodak, and Piker. In fact, if every woman were to follow ACS and NCI mammography guidelines, the annual revenue to health care facilities would be a staggering $5 billion, including at least $2.5 billion for premenopausal women. Promotions of the ACS continue to
    lure women of all ages into mammography centers, leading them to believe that mammography is their best hope against breast cancer. A leading Massachusetts newspaper featured a photograph of two women in their twenties in an ACS advertisement that promised early detection results in a cure “nearly 100 percent of the time.” An ACS communications director, questioned by journalist Kate Dempsey, responded in an article published by the Massachusetts Women’s
    Community’s journal Cancer: “The ad isn’t based on a study. When you make an advertisement, you just say what you can to get women in the door. You exaggerate a point. . . . Mammography today is a lucrative [and] highly competitive business.”

    In addition, the mammography industry conducts research for the ACS and its grantees, serves on advisory boards, and donates considerable funds. DuPont also is a substantial backer of the ACS Breast Health Awareness Program; sponsors television shows and other media productions touting mammography; produces advertising, promotional, and information literature for hospitals, clinics, medical organizations, and doctors; produces educational films; and, of course, lobbies Congress for legislation promoting availability of mammography services. In virtually all of its important actions, the ACS has been strongly linked with the mammography industry, ignoring the development of viable alternatives to mammography.

    The ACS exposes premenopausal women to radiation hazards from mammography with little or no evidence of benefits. The ACS also fails to tell them that their breasts will change so much over time that the “baseline” images have little or no future relevance. This is truly an American Cancer Society crusade. But against whom, or rather, for whom?

    National Breast Cancer Awareness Month
    The highly publicized National Breast Cancer Awareness Month campaign further illustrates these institutionalized conflicts of interest. Every October, ACS and NCI representatives help sponsor promotional events, hold interviews, and stress the need for mammography. The flagship of this month-long series of
    events is National Mammography Day, on October 17 in 1997.
    Conspicuously absent from the public relations campaign of the National Breast Cancer Awareness Month is any information on environmental and other avoidable causes of breast cancer. This is no accident. Zeneca Pharmaceuticals— a spin-off of Imperial Chemical Industries, one of the world’s largest manufacturers of chlorinated and other industrial chemicals, including those incriminated as causes of breast cancer— has been the sole multimillion-dollar funder of
    National Breast Cancer Awareness Month since its inception in 1984. Zeneca is also the sole manufacturer of tamoxifen, the world’s top-selling anticancer and breast cancer “prevention” drug, with $400 million in annual sales. Furthermore, Zeneca recently assumed direct management of 11 cancer centers in U. S. hospitals. Zeneca owns a 50 percent stake in these centers known collectively as Salick
    Health Care.

    The link between the ACS and NCI and Zeneca is especially strong when it comes to tamoxifen. The ACS and NCI continue aggressively to promote the tamoxifen trial, which is the cornerstone of its minimal prevention program. On March 7, 1997, the NCI Press Office released a four-page “For Response to Inquiries on Breast Cancer.” The brief section on prevention reads:

    “ Researchers are looking for a way to prevent breast cancer in women at high risk. … Alargestudy [is underway] to see if the drug tamoxifen will reduce cancer risk in women age 60 or older and in women 35 to 59 who have a pattern of risk factors for breast cancer. This study is also a model for future studies of cancer prevention. Studies of diet and nutrition could also lead to preventive strategies.”

    Since Zeneca influences every leaflet, poster, publication, and commercial produced by National Breast Cancer Awareness Month, it is no wonder these publications make no mention of carcinogenic industrial chemicals and their relation to breast cancer. Imperial Chemical Industries, Zeneca’s parent company, profits by manufacturing breast cancer– causing chemicals. Zeneca profits from treatment of breast cancer, and hopes to profit still more from the prospects of large-scale national use of tamoxifen for breast cancer prevention. National Breast Cancer Awareness Month is a masterful public relations coup for Zeneca, providing the company with valuable, if ill-placed, good will from millions of American women.

    The Pesticide Industry
    Just how inbred the relations between the ACS and the chemical industry are became clear in the spring of 1993 to Marty Koughan, a public television producer. Koughan was about to broadcast a documentary on the dangers of pesticides to children for the Public Broadcasting Service’s hour-long show, Frontline. Koughan’s investigation relied heavily on an embargoed, ground-breaking report
    issued by the National Academy of Sciences in June of 1993 entitled “Pesticides in the Diet of Children.” This report declared the nation’s food supply “inadequately protected” from cancer-causing pesticides and a significant threat to the health of children.

    An earlier report, issued by the Natural Resources Defense Council in 1989,” Intolerable Risk: Pesticides in our Children’s Food,” had also given pesticide manufacturers failing marks. The report was released in high profile testimony to Congress by movie actress Meryl Streep. A mother of young children, Streep explained to a packed House chamber the report’s findings, namely, that children were most at risk from cancer-causing pesticides on our food because they consume
    a disproportionate amount of fruits, fruit juices, and vegetables relative to their size, and because their bodies are still forming. Shortly before Koughan’s program was due to air, a draft of the script was mysteriously leaked to Porter- Novelli, a powerful public relations firm for produce growers and the agrichemical industry. In true Washington fashion, Porter-Novelli plays both sides of the fence, representing both government agencies and the industries they regulate. Its client list in 1993 included Ciba-Geigy, DuPont, Monsanto, Burroughs
    Wellcome, American Petroleum Institute, Bristol-Meyers-Squibb,
    Hoffman-LaRoche, Hoechst Celanese, Hoechst Roussel Pharmaceutical, Janssen Pharmaceutical, Johnson & Johnson, the Center for Produce Quality, as well as the U. S. Department of Agriculture, the NCI, plus other National Institutes of Health.

    Porter-Novelli first crafted a rebuttal to help the manufacturers quell public fears about pesticide-contaminated food. Next, Porter-Novelli called up another client, the American Cancer Society, for whom Porter-Novelli had done pro bono work for years. The rebuttal that Porter-Novelli had just sent off to its industry clients was faxed to ACS Atlanta headquarters. It was then circulated by e-mail on March 22, 1993, internally— virtually verbatim from the memo Porter-Novelli
    had crafted for a backgrounder for 3,000 regional ACS offices to have in hand to help field calls from the public after the show aired.

    ” The program makes unfounded suggestions . . . that pesticide residue in food may be at hazardous levels,” the ACS memo read. “Its use of `cancer cluster’ leukemia case reports and non-specific community illnesses as alleged evidence of pesticide effects in people is unfortunate. We know of no community cancer clusters
    which have been shown to be anything other than chance grouping of cases and none in which pesticide use was confirmed as the cause.”
    This bold, unabashed defense of the pesticide industry, crafted by Porter- Novelli, was then rehashed a third time, this time by the right-wing group, Accuracy in Media (AIM). AIM’s newsletter gleefully published quotes from the ACS memo in an article with the banner headline: “Junk Science on PBS.” The article opened with “Can we afford the Public Broadcasting Service?” and went on to disparage Koughan’s documentary on pesticides and children. “In Our
    Children’s Food . . . exemplified what the media have done to produce these `popular panics’ and the enormously costly waste [at PBS] cited by the New York Times.”

    When Koughan saw the AIM article he was initially outraged that the ACS was being used to defend the pesticide industry. “At first, I assumed complete ignorance on the part of the ACS,” said Koughan. But after repeatedly trying, without success, to get the national office to rebut the AIM article, Koughan began to see what was really going on. “When I realized Porter-Novelli represented five agrichemical companies, and that the ACS had been a client for years,
    it became obvious that the ACS had not been fooled at all,” said Koughan. “They were willing partners in the deception, and were in fact doing a favor for a friend— by flakking for the agrichemical industry.”
    Charles Benbrook, former director of the National Academy of Sciences Board of Agriculture, worked on the pesticide report by the Academy of Sciences that the PBS special would preview. He charged that the role of the ACS as a source of information for the media representing the pesticide and produce industry was “unconscionable” (11). Investigative reporter Sheila Kaplan, in a 1993
    Legal Times article, went further: “What they did was clearly and unequivocally over the line, and constitutes a major conflict of interest” (12).

    Cancer Drug Industry
    The intimate association between the ACS and the cancer drug industry, with cur-rent annual sales of about $12 billion, is further illustrated by the unbridled aggression which the Society has directed at potential competitors of the industry (13). Just as Senator Joseph McCarthy had his “black list” of suspected communists and Richard Nixon his environmental activist “enemies list,” so too the ACS
    maintains a “Committee on Unproven Methods of Cancer Management” which periodically “reviews” unorthodox or alternative therapies. This Committee is comprised of “volunteer health care professionals,” carefully selected proponents of orthodox, expensive, and usually toxic drugs patented by major pharmaceutical companies, and opponents of alternative or “unproven” therapies which are
    generally cheap, nonpatentable, and minimally toxic (13).

    Periodically, the Committee updates its statements on “unproven methods,” which are then widely disseminated to clinicians, cheerleader science writers, and the public. Once a clinician or oncologist becomes associated with “unproven methods,” he or she is blackballed by the cancer establishment. Funding for the
    accused “quack” becomes inaccessible, followed by systematic harassment. The highly biased ACS witch-hunts against alternative practitioners is in striking contrast to its extravagant and uncritical endorsement of conventional toxic chemotherapy. This in spite of the absence of any objective evidence of improved survival rates or reduced mortality following chemotherapy for all but some relatively
    rare cancers.

    In response to pressure from People Against Cancer, a grassroots group of cancer patients disillusioned with conventional cancer therapy, in 1986 some 40 members of Congress requested the Office of Technology Assessment (OTA), a Congressional think tank, to evaluate available information on alternative innovative therapies. While initially resistant, OTA eventually published a September 1990 report that identified some 200 promising studies on alternative
    therapies. OTA concluded that the NCI had “a mandated responsibility to pursue this information and facilitate examination of widely used `unconventional cancer treatments’ for therapeutic potential” (14).

    Yet the ACS and NCI remain resistant, if not frankly hostile, to OTA’s recommendations. In the January 1991 issue of its Cancer Journal for Clinicians ACS referred to the Hoxsey therapy, a nontoxic combination of herb extracts developed in the 1940s by populist Harry Hoxsey, as a “worthless tonic for cancer.” However, a detailed critique of Hoxsey’s treatment by Dr. Patricia Spain Ward, a leading contributor to the OTA report, concluded just the opposite:” More recent literature leaves no doubt that Hoxsey’s formula does indeed contain many plant substances of marked therapeutic activity” (13).

    Nor is this the first time that the Society’s claims of quackery have been called into question or discredited. A growing number of other innovative therapies originally attacked by the ACS have recently found less disfavor and even acceptance. These include hyperthermia, tumor necrosis factor (originally called Coley’s toxin), hydrazine sulfate, and Burzynski’s antineoplastons. Well over 100 promising alternative nonpatented and nontoxic therapies have already been identified (15). Clearly, such treatments merit clinical testing and evaluation by
    the NCI using similar statistical techniques and criteria as established for conventional chemotherapy. However, while the FDA has approved approximately 40 patented drugs for cancer treatment, it has still not approved a single nonpatented alternative drug.

    Subsequent events have further isolated the ACS in its fixation on orthodox treatments. Bypassing the ACS and NCI, the National Institutes of Health in June 1992 opened a new Office of Alternative Medicine for the investigation of unconventional treatment of cancer and other diseases. Leading proponents of conventional therapy were invited to participate. The ACS refused and still refuses. The NCI grudgingly and nominally participates while actively attacking
    alternative therapy with its widely circulated Cancer Information Services. Meanwhile, the NCI’s police partner, the FDA, uses its enforcement authority against distributors and practitioners of innovative and nontoxic therapies. In an interesting recent development, the Center for Mind-Body Medicine in Washington, D. C., held a two-day conference on Comprehensive Cancer Care: Integrating Complementary and Alternative Medicine. According to Dr. James Gordon, president of the Center and chair of the Program Advisory Council of the NIH Office of Alternative Medicine, the object of the conference was to bring together practitioners of mainstream and alternative medicine, together with cancer patients and high-ranking officials of the ACS and NCI. Dr. Gordon warned alternative practitioners that “they’re going to need to get more rigorous
    with their work— to be accepted by the mainstream community” (16). However, no such warning was directed at the highly questionable claims by the NCI and ACS for the efficacy of conventional cancer chemotherapy. As significantly, criticism of the establishment’s minimalistic priority for cancer prevention was effectively discouraged.

    THE ROLE OF ACS IN THE WAR AGAINST CANCER
    The launching of the 1971 War Against Cancer provided the ACS with a well-exploited opportunity to pursue it own myopic and self-interested agenda. Its strategies remain based on two myths— that there has been dramatic progress in the treatment and cure of cancer, and that any increase in the incidence and mortality of cancer is due to aging of the population and smoking, while denying any significant role for involuntary exposures to industrial carcinogens in air, water, consumer products, and the workplace.

    As the world’s largest nonreligious “charity,” with powerful allies in the private and public sectors, ACS policies and priorities remain unchanged. Despite periodic protests, threats of boycotts, and questions on its finances, the Society leadership responds with powerful public relations campaigns reflecting denial and manipulated information and pillorying its opponents with scientific McCarthyism.

    The verdict is unassailable. The ACS bears a major responsibility for losing the winnable war against cancer. Reforming the ACS is, in principle, relatively easy and directly achievable. Boycott the ACS. Instead, give your charitable contributions to public interest and environmental groups involved in cancer prevention. Such a boycott is well overdue and will send the only message this “charity” can no longer ignore. The Cancer Prevention Coalition (chaired by the author) in April 1999 formally announced a nationwide campaign for an economic boycott of the ACS ( http://www.preventcancer.com).

    Published in: International Journal of Health Services Vol. 29, No. 3, 1999.

    REFERENCES
    1. Bennett, J. T. Health research charities: Doing little in research but emphasizing politics. Union Leader, Manchester, N. H., September 20, 1990.

    2. Bennett, J. T., and DiLorenzo, T. J. Unhealthy Charities: Hazardous to Your Health and Wealth. Basic Books, New York, 1994.

    3. Hall, H., and Williams, G. Professor vs. Cancer Society. The Chronicle of Philanthropy, January 28, 1992, p. 26.

    4. DiLorenzo, T. J. One charity’s uneconomic war on cancer. Wall Street Journal, March 15, 1992, p. A10.

    5. Salant, J. D. Cancer Society gives to governors. Associated Press Release, March 30, 1998.

    6. Epstein, S. S., Steinman, D., and LeVert, S. The Breast Cancer Prevention Program. Macmillan, New York, 1997.

    7. Epstein, S. S. Losing the war against cancer: Who’s to blame and what to do about it. Int. J. Health Serv. 20: 53– 71, 1990.

    8. Epstein, S. S. Evaluation of the National Cancer Program and proposed reforms. Int. J. Health Serv. 23( 1): 15– 44, 1993.

    9. American Cancer Society. Upcoming television special on pesticides in food. Memorandum from S. Dickinson, Vice-President, Public Relations and Health, to C. W. Heath, Jr., M. D., Vice-President. Epidemiology and Statistics, March 22, 1993.

    10. American Cancer Society. Cancer Facts & Figures— 1998, pp. 1– 32, Atlanta, 1998.

    11. Kaplan, S. PR Giant makes hay from client cross-pollination: Porter/ Novelli plays all sides. PR Watch, First quarter, 1994, p. 4.

    12. Kaplan, S. Porter-Novelli plays all sides. Legal Times 16( 27) :1, November 23, 1993.

    13. Moss, R. W. Questioning Chemotherapy. Equinox Press, Brooklyn, N. Y., 1995.

    14. U. S. Congress Office of Technology Assessment. Unconventional Cancer Treatments. U. S. Government Printing Office, Washington, D. C., 1990.

    15. Moss. R. W. Cancer Therapy: The Independent Consumer’s Guide to Non-toxic Treatment and Prevention. Equinox Press, Brooklyn, N. Y., 1992.

    16. Castellucci, L. Practitioners seek common ground in unconventional forum. J. Natl. Cancer Inst. 90: 1036– 1037, 1998.

    Contact:

    Samuel S. Epstein, M.D.
    University of Illinois at Chicago

    School of Public Health, MC 922
    2121 W. Taylor Street
    Chicago, IL 60612-7260

  27. #27 Robespierre
    November 12, 2009

    So, we know the expression, ‘nom de plume’, do we? That’s a fine start toward earning your Boy Scout badge in Sophistication, but I’ll explain to you why dyspeptic remarks (less by you & more by Marilynn Marchionne) disparaging unconventional medical approaches to disease may in the long run have very negative consequences for the advancement of health sciences.

    In the 1970s I was a graduate student in Economics at the U of Chicago. I took 5 courses from Prof Milton Friedman & audited several others. He earned the respect of his students for a host of reasons (including his brilliance & tolerance of those who were less bright than he), but also because he REFUSED to think conventionally & customarily about economic problems. He was a superb ‘neo-Aristotelian’ researcher in the sense that he did not try to impose his preconceptions on data, but he rather used the data as the basis for legitimate economic conclusions. As a comic might say, Prof Friedman didn’t look for answers where the light was good, he looked for answers wherever he could find them.

    One of his most unpopular positions (& he had many) was that he was opposed to the licensure of physicians. He heartily supported ‘certification’ (i.e., a physician must take & pass a particular course of academic work), but ‘licensure’ (a process whereby one’s ability to practice & to earn a living is potentially at jeopardy from the whims of a panel or a board of so-called peers) was the slippery slope to an intellectual Inquisition (I assume that I don’t have to review with you the story of Galileo, Pope Urban VIII & the concept of heliocentrism).

    The net of Prof Friedman’s argument against licensure is this: yes, there will be thousands – possibly tens of thousands – of fakes & charlatans selling their wares in the marketplace of cures & remedies. NONETHELESS, we must tolerate this because of the one or 2 LEGITIMATE new ideas which will lift our scientific knowledge to a different level.

    I’m certain that Marilynn Marchione believes that she’s doing the world (& many individuals) a wonderful service. The chance of that proposition being true is both slim and arguable.

  28. #28 Heather Stock
    December 9, 2009

    The people that I know who are into natural remedies, are healthier people leading healthy lives as compared to most people who take presciption drugs, and struggle with their health – I find they have a very poor sense of diet and exercise routine – they are very misinformed and brainwashed to the modern medicine. Pharmaceutical companies and governments do a great job with news reports to brain wash the average person. For me personally, I’ve never been healthier. I am completely drug free. I daily take vitamins which include: chloraphyl, folic acid, calcium citrate, 2000 iu of Vit D., Vitamin C, and also super antioxidants. I also mix a packet of VSL#3 into my fat free natural yogurt by Organic Meadow. This keeps my pelvic pouch and small intenstines in healthy order, as I lost my colon due to ulcerative colitis. Drugs and modern medicine such as prednisone and antibiodics – cipro and flagyl did not help me for very long. The side effects of these chemical drugs are awful too. My hair was dry, I was under weight and weak. Now I’m the healthiest I’ve ever been — I’ve also gone off all wheat and corn. I believe Genetically Modified Foods are very bad. The pharmiceutical/biotech companies are all in on that too. Disease and Modern Medicine is a big vicious cycle that will never end until the masses seek out “natural” ways of healing our bodies and eating, exercising, sleeping. How about banning coffee, fast food, pop, all high fructose corn syrup products, processed foods, GMO seeds, glade plug-in deodorizers, ….. perhaps then we’ll see our health improve. Open your mind people – don’t be closed minded!